[Indirect immunofluorescence with monoclonal antibodies in the diagnosis of Pneumocystis carinii. Preliminary report] NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Indirect immunofluorescence with monoclonal antibodies in the diagnosis of Pneumocystis carinii. Preliminary report]

Rev Med Chil. 1991 Mar;119(3):293-4. Unique Identifier : AIDSLINE MED/93067737
Weitz JC; Astorga B; Laboratorio de Referencia de Parasitologia, Instituto de Salud; Publica, Santiago de Chile.

Abstract: We compared traditional methods based on argentic metamine and toluidine blue staining vs recently introduce techniques based on immunofluorescence for monoclonal antibodies in the diagnosis of P. carinii. Fifty samples were analyzed: 29 (58%) were negative by all method. Of the remaining 21.72% were positive for immunofluorescence, 67% for argentic and 48% for toluidine blue staining. Thus, immunofluorescence techniques represent an improvement in the ability to diagnose infection by P carinii.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Antibodies, Monoclonal/*DIAGNOSTIC USE Antibodies, Protozoan/*ANALYSIS/IMMUNOLOGY Comparative Study English Abstract *Fluorescent Antibody Technique Human Pneumonia, Pneumocystis carinii/*DIAGNOSIS Sensitivity and Specificity JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/complicationsantibodies,monoclonal/KWDdiagnosticuseantibodies,protozoan/KWDanalysis/immunologycomparativestudyenglishabstractKWDfluorescentantibodytechniquehumanpneumonia,pneumocystiscarinii/KWDdiagnosissensitivityandspecificityjournalarticle
930228
M9320850

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .